{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:47:30Z","timestamp":1782175650186,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.117083","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:17:29Z","timestamp":1720109849000},"page":"117083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dendritic cells pulsed with penetratin-OLFM4 inhibit the growth and metastasis of melanoma in mice"],"prefix":"10.1016","volume":"177","author":[{"given":"Bum-Seo","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunmi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Woong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-In","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yong","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117083_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fonc.2019.00626","article-title":"Stem cell plasticity and dormancy in the development of cancer therapy resistance","volume":"9","author":"De Angelis","year":"2019","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117083_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2012.13","article-title":"Understanding cancer stem cell heterogeneity and plasticity","volume":"22","author":"Tang","year":"2012","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.biopha.2024.117083_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/antib9030034","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.biopha.2024.117083_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3389\/fimmu.2017.01245","article-title":"Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going?","volume":"8","author":"Marshall","year":"2017","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-020-00947-6","article-title":"Targeting immune checkpoints in hematological malignancies","volume":"13","author":"Salik","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117083_bib6","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-15-1433","article-title":"Making better chimeric antigen receptors for adoptive t-cell therapy","volume":"22","author":"Maus","year":"2016","journal-title":"Clin. Cancer Res"},{"issue":"13","key":"10.1016\/j.biopha.2024.117083_bib7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood.2022016226","article-title":"CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights","volume":"140","author":"Ali","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-020-00862-w","article-title":"Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy","volume":"13","author":"Pan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13073-022-01138-3","article-title":"Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution","volume":"14","author":"Thol","year":"2022","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12964-024-01643-5","article-title":"Signaling, cancer cell plasticity, and intratumor heterogeneity","volume":"22","author":"Cordani","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2024.117083_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3389\/fonc.2019.01115","article-title":"Insights into mechanisms of tumor and immune system interaction: association with wound healing","volume":"9","author":"Ponomarev","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2024.117083_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117083_bib13","first-page":"689","article-title":"Cancer stem cells and immunoresistance: clinical implications and solutions","volume":"4","author":"Codony-Servat","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.117083_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2024.117083_bib15","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/stem.2039","article-title":"Concise review: targeting cancer stem cells using immunologic approaches","volume":"33","author":"Pan","year":"2015","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3892\/ol.2015.3172","article-title":"Targeted therapy against cancer stem cells","volume":"10","author":"Yang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-023-01748-4","article-title":"Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.117083_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2001-1326-3-19","article-title":"SOX2 and cancer: current research and its implications in the clinic","volume":"3","author":"Weina","year":"2014","journal-title":"Clin. Transl. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.117083_bib19","doi-asserted-by":"crossref","first-page":"9559","DOI":"10.1007\/s11033-023-08768-9","article-title":"Immunobiology of cancer stem cells and their immunoevasion mechanisms","volume":"50","author":"Marzban","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2024.117083_bib20","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/stem.102","article-title":"Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens","volume":"27","author":"Xu","year":"2009","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.biopha.2024.117083_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/imm.12866","article-title":"Cancer stem cells as targets for immunotherapy","volume":"153","author":"Codd","year":"2018","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.biopha.2024.117083_bib22","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic cell-based immunotherapy: state of the art and beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","article-title":"OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells","volume":"137","author":"van der Flier","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2024.117083_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2009.01.031","article-title":"Transcription factor achaete scute-like 2 controls intestinal stem cell fate","volume":"136","author":"van der Flier","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2024.117083_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.stem.2012.09.009","article-title":"Identifying the stem cell of the intestinal crypt: strategies and pitfalls","volume":"11","author":"Barker","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.biopha.2024.117083_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10555-010-9262-z","article-title":"Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis","volume":"29","author":"Grover","year":"2010","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.117083_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1349-7006.2007.00397.x","article-title":"Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells","volume":"98","author":"Kobayashi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2024.117083_bib28","doi-asserted-by":"crossref","first-page":"1072685","DOI":"10.3389\/fphar.2022.1072685","article-title":"Cell penetrating peptide: a potent delivery system in vaccine development","volume":"13","author":"Hasannejad-Asl","year":"2022","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2024.117083_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-6147(03)00076-2","article-title":"Protein transduction domains: are they delivering?","volume":"24","author":"Green","year":"2003","journal-title":"Trends Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4110\/in.2016.16.1.33","article-title":"Use of cell-penetrating peptides in dendritic cell-based vaccination","volume":"16","author":"Lim","year":"2016","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117083_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20030167","article-title":"The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation","volume":"198","author":"Bajenoff","year":"2003","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.117083_bib33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution","volume":"137","author":"Steinman","year":"1973","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.117083_bib34","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.117083_bib35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"20","key":"10.1016\/j.biopha.2024.117083_bib36","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2009-04-215020","article-title":"GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE)","volume":"114","author":"Hiasa","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biopha.2024.117083_bib37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2353\/ajpath.2008.070360","article-title":"Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment","volume":"172","author":"Koyama","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"27","key":"10.1016\/j.biopha.2024.117083_bib39","doi-asserted-by":"crossref","first-page":"42698","DOI":"10.18632\/oncotarget.8311","article-title":"Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy","volume":"7","author":"Dufait","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.20021542","article-title":"Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation","volume":"198","author":"Delamarre","year":"2003","journal-title":"J. Exp. Med"},{"issue":"16","key":"10.1016\/j.biopha.2024.117083_bib41","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djt184","article-title":"MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells","volume":"105","author":"Leone","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.biopha.2024.117083_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117083_bib43","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.4161\/hv.29276","article-title":"DCVax(R)-L--developed by Northwest Biotherapeutics","volume":"10","author":"Polyzoidis","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7774\/cevr.2018.7.1.16","article-title":"Distinct features of dendritic cell-based immunotherapy as cancer vaccines","volume":"7","author":"Lee","year":"2018","journal-title":"Clin. Exp. Vaccin. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.117083_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/tra.12026","article-title":"Presentation of phagocytosed antigens by MHC class I and II","volume":"14","author":"Mantegazza","year":"2013","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.biopha.2024.117083_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.292","article-title":"Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes","volume":"50","author":"Min","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.117083_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)00038-6","article-title":"Developmental control of endocytosis in dendritic cells by Cdc42","volume":"102","author":"Garrett","year":"2000","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.biopha.2024.117083_bib48","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s00018-018-2785-0","article-title":"Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines","volume":"75","author":"Grau","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.biopha.2024.117083_bib49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tibtech.2003.09.008","article-title":"Biological applications of protein transduction technology","volume":"21","author":"Kabouridis","year":"2003","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117083_bib50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/156652312802762527","article-title":"Protein transduction domains: applications for molecular medicine","volume":"12","author":"Zahid","year":"2012","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117083_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40425-019-0580-6","article-title":"The clinical application of cancer immunotherapy based on naturally circulating dendritic cells","volume":"7","author":"Bol","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2024.117083_bib53","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.4049\/jimmunol.1501657","article-title":"Landscape of tumor antigens in T cell immunotherapy","volume":"195","author":"Ilyas","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117083_bib54","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117083_bib55","first-page":"526","article-title":"Dendritic cells in immunotherapy of established cancer: roles of signals 1, 2, 3 and 4","volume":"10","author":"Kalinski","year":"2009","journal-title":"Curr. Opin. Invest. Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2024.117083_bib56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/mt.2011.57","article-title":"Engineering dendritic cells to enhance cancer immunotherapy","volume":"19","author":"Boudreau","year":"2011","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.117083_bib57","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/carcin\/bgr065","article-title":"Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1","volume":"32","author":"Chen","year":"2011","journal-title":"Carcinogenesis"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:58:16Z","timestamp":1782172696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224009673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":57,"alternative-id":["S0753332224009673"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117083","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells pulsed with penetratin-OLFM4 inhibit the growth and metastasis of melanoma in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117083"}}